Jason Paul Steik
Chief Clinical Officer, Pennant Group, Inc.
Companies
- Pennant Group, Inc.Chief Clinical Officer Jul 31, 2025 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Pennant Group, Inc. PNTG15,106 shares2$610.7K at $40.43Aug 6, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 6, 2026Sold 1,394 shares at $38.52 of Pennant Group, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2